What is Emergent Biosolutions's change in inventories?

Emergent Biosolutions (EBS) reported change in inventories of -$15.8M in Q1 2026.

How has Emergent Biosolutions's change in inventories changed year-over-year?

Emergent Biosolutions's change in inventories decreased by 818.2% year-over-year, from $2.2M to -$15.8M.

What does change in inventories mean?

Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.

Emergent Biosolutions EBS Change in Inventories

Change in Inventories at other companies

Regeneron PharmaceuticalsREGN

-$26.6M-117%

AMP

Amphastar PharmaceuticalsAMPH

-$6.25M-120%

Amneal Pharmaceuticals, Inc.AMRX

$54.96M+314%

CorMedixCRMD

$1.02M+1,006%

Collegium Pharmaceutical, Inc.COLL

$1.83M+10.3%

Opko HealthOPK

-$191K-104%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's change in inventories?: Emergent Biosolutions (EBS) reported change in inventories of -$15.8M in Q1 2026.
How has Emergent Biosolutions's change in inventories changed year-over-year?: Emergent Biosolutions's change in inventories decreased by 818.2% year-over-year, from $2.2M to -$15.8M.
What does change in inventories mean?: Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.